Funded Projects

Top Funded Faculty

Based on current funded research

Current Funded Research

Updated February 9, 2022
Data provided by University at Buffalo Sponsored Projects Services

Award Principal Investigator Award Name Award Type Sponsor Name Award Start Date Award End Date Total Cost
Balthasar, Dr. Joseph Catch and Release Immunotoxins: CAR-Bombs for Cancer Federal National Cancer Institute 7-Dec-16 30-Nov-21 1,816,235.00
Balthasar, Dr. Joseph Center for Protein Therapeutics Nonfederal Multiple Sponsors 1-Sep-17 31-Aug-22 7,199,501.70
Balthasar, Dr. Joseph Pharmacokinetic strategies to increase monoclonal antibody uptake, distribution, and efficacy for treatment of solid tumors Federal National Cancer Institute 1-Jun-20 31-May-25 1,814,481.00
Balthasar, Dr. Joseph Enhancement of ADC selectivity by inverse targeting: Mechanistic studies and optimization Federal National Cancer Institute 1-Jun-21 31-May-26 1,824,363.00
Balu-Iyer, Dr. Sathy V Tolerance Inducing Phosphatidylserine (TIPS): a nanoparticle-based platform for immunotherapy Nonfederal Empire Discovery Institute 13-May-21 13-May-22 102,480.00
Balu-Iyer, Dr. Sathy V Development of Lipid Based Platform for Nucleic Acid Delivery Nonfederal University of Rochester 01-Apr-2021 31-Mar-2022 20,000.00
Bednarczyk, Dr. Edward M C19: Chronic Disease Medication Utilization and the Novel Coronavirus Disease 2019 (COVID-19) Infection Nonfederal American College of Clinical Pharmacy 1-Jan-21 31-Dec-21 600.00
Bednarczyk, Dr. Edward M NYS Prescription Monitoring CE Program Federal Flow Through Island Peer Review Organization 1-Sep-21 31-Oct-22 12,632.00
Bies, Dr. Robert R. Physiologically-based model of the female reproductive tract: vaginal and intrauterine delivery components- Support New Approaches to Improve Product Manufacturing and Quality Federal US Food and Drug Administration 26-Sep-18 25-Jan-24 940,749.00
Bies, Dr. Robert R. Film Antiretroviral Microbicide Evaluation Federal Flow Through Magee-Womens Research Institute and Foundation 01-Jun-2019 31-May-2022 405,130.00
Bies, Dr. Robert R. Pharmacokinetics of sedatives - Understanding a modifiable risk factor for pediatric delirium Federal Flow Through Childrens Research Institute 1-Sep-19 31-Jul-24 30,566.00
Bies, Dr. Robert R. Long Acting Film Technology for Contraception and HIV Prevention (LATCH) Federal Flow Through Magee-Womens Research Institute and Foundation 1-Feb-21 31-Jan-22 40,060.00
Bies, Dr. Robert R. Evaluation of safety and pharmacokinetics of naltrexone implant Federal Flow Through Research Foundation for Mental Hygiene 1-Mar-21 28-Feb-22 70,875.00
Bies, Dr. Robert R. The Indiana University-Ohio State University Maternal and Pediatric Precision in Therapeutics Data, Model, Knowledge, and Research Coordination Center (IU-OSU MPRINT DMKRCC) Federal Flow Through Trustees of Indiana University 10-Sep-2021 31-Jul-2026 1,920,718.00
Bies, Dr. Robert R. Population Pharmacokinetic Modeling and Clinical Trial Simulation to optimize HIV Prevention in Pregnancy and Postpartum Federal Flow Through Johns Hopkins University 01-Aug-2021 31-Jul-2022 74,176.00
Bies, Dr. Robert R. Microbicide R&D to Advance HIV Prevention Technologies through Responsive Innovation and eXcellence, MATRIX Federal Flow Through Magee-Womens Research Institute and Foundation 01-Dec-2021 31-Dec-2026 993,854.00
Blanco, Dr. Javier Defining the Contribution of Cellular Hypoxia to the Cardiotoxicity of Anticancer Anthracyclines and Trastuzumab Federal National Institute of General Medical Sciences 1-Sep-19 31-Aug-21 248,247.46
Blanco, Dr. Javier Understanding the Molecular Underpinnings of Anthracycline-related Cardiomyopathy in Childhood Cancer Survivors Nonfederal Board of Trustees of the University of Alabama Birmingham 1-Feb-19 31-Jan-22 54,369.00
Blanco, Dr. Javier Evaluation of myocardial targets to prevent anthracycline cardiotoxicity in children with Down Syndrome and Leukemia Federal National Cancer Institute 23-Sep-19 31-Aug-21 438,625.00
Blanco, Dr. Javier The Who and Why of Anthracycline-related Cardiotoxicity in Childhood Cancer Survivors Nonfederal Board of Trustees of the University of Alabama Birmingham 1-Jul-19 30-Jun-22 37,238.00
Chilbert, Dr. Maya Rachael Comparison of Triple Theraply with Apixaban vs. Rivaroxaban Nonfederal American College of Clinical Pharmacy 1-Jul-20 31-Dec-21 4,000.00
Jacobs, Dr. David Matthew Impact of an Integrated Pharmacist and Primary Care Collaborative Transitions of Care Program on Clinical and economic Outcomes among High Risk Patients Nonfederal ASHP Research and Education Foundation 01-Jul-2019 30-Jun-2022 75,000.00
Jacobs, Dr. David Matthew Impact and feasibility of establishing a Community Health Worker Program within Community Pharmacy Settings Nonfederal Community Pharmacy Foundation 1-Jan-20 1-Oct-21 39,533.00
Jacobs, Dr. David Matthew A qualitative study to understand patient and social factors related to nebulizer use at the transition of care in COPD Nonfederal Mylan Incorporated 15-Nov-19 1-Oct-21 38,682.00
Jacobs, Dr. David Matthew Integrative Informatics Approach to Predict Readmissions and Improve Outcomes in COPD Federal National Heart Lung and Blood Institute 1-Apr-21 31-Mar-26 962,055.00
Jacobs, Dr. David Matthew Improving the Health of Americans through Prevention and Management of Diabetes and Heart Disease and Stroke Federal Flow Through Community Pharmacy Enhanced Services Network 30-Jun-2021 29-Jun-2022 45,000.00
Jusko, Dr. William J Mechanistic Pharmacokinetics and Pharmacodynamics Federal National Institute of General Medical Sciences 1-May-19 30-Apr-24 2,891,677.00
Jusko, Dr. William J Training Program in Pharmacokinetics and Pharmacodynamics Nonfederal GlaxoSmithKline 3-Feb-21 2-Feb-23 255,200.00
Ma, Dr. Qing Doravirine Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals Nonfederal Merck Sharp and Dohme Corporation 04-Jun-2019 04-Jun-2022 142,500.01
Ma, Dr. Qing Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV Federal National Institute on Aging 1-May-20 28-Feb-25 4,006,139.00
Ma, Dr. Qing Bictegravir in the Elderly Living with HIV: Impact of Polypharmacy and Multimorbidity Nonfederal Gilead Sciences Incorporated 1-Oct-19 29-Sep-22 67,270.00
Mager, Dr. Donald E Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments Federal Flow Through Childrens Hospital of Boston 1-Sep-18 30-Jun-23 655,055.00
Mager, Dr. Donald E Optimizing GVHD Prevention with Systems Pharmacology Models Federal Flow Through Beckman Research Institute of the City of Hope 1-Jun-19 31-May-24 549,900.00
Mager, Dr. Donald E Mechanistic PKPD modelling of biologic treatments in lymphoid leukemia for better understanding of efficacy and safety Foreign Institut de Recherches Internationales Servier 1-Aug-19 31-Jul-22 227,090.00
Mager, Dr. Donald E Genetic and Epigenetic Vulnerabilities in Prostate Cancer of African American Men Federal Flow Through Health Research Inc 01-Aug-2021 31-Jul-2022 55,713.00
Meaney, Dr. Calvin J. Optimizing Vancomycin Use and Clinical Outcomes in Hemodialysis Patients Nonfederal American College of Clinical Pharmacy 1-Jan-21 31-Dec-21 3,000.00
Morris, Dr. Marilyn E SBIR: Development of Novel PDE4B Inhibitors to Treat Alcohol Use Disorder Federal Flow Through Codex BioSolutions Incorporated 23-Sep-19 22-Sep-21 73,459.00
Morse, Dr. Gene Clinical Pharmacology Quality Assurance Federal National Institute of Allergy & Infectious Disease 30-May-15 29-May-22 10,687,100.92
Morse, Dr. Gene HIV Research Training Program Federal Fogarty International Center 1-Apr-16 28-Feb-22 1,884,534.00
Morse, Dr. Gene Global Infectious Diseases Research Training Program Federal Fogarty International Center 11-Apr-18 28-Feb-23 1,125,653.00
Morse, Dr. Gene ACTG Precautionary and Prohibited Medications Database Federal Flow Through Regents of the University of California Los Angeles 01-Dec-2020 30-Nov-2021 190,000.00
Morse, Dr. Gene ACTG Pharmacology Specialty Laboratory Federal Flow Through Regents of the University of California Los Angeles 1-Dec-20 30-Nov-27 1,953,875.00
Morse, Dr. Gene C19: WNY COVID-19 Research Collaborative Nonfederal John R Oishei Foundation 1-Jun-21 31-Dec-21 54,450.00
Morse, Dr. Gene A Pilot Study to Investigate the Pharmacokinetic Properties of single- and multi-dose administration of a commercially available full-spectrum hemp-based CBD extract in Healthy Volunteers Nonfederal Dent Neuroscience Research Center 11-Aug-2021 30-Nov-2022 63,468.00
Morse, Dr. Gene University of Rochester HIV/AIDS Clinical Trial Unit - AWD00003932 Federal Flow Through University of Rochester 01-Dec-2020 30-Nov-2027 56,847.00
Morse, Dr. Gene C19: NYU: CBD, Morphine, Hydrocodone, and Oxycodone levels in human plasma samples Nonfederal New York University 01-Dec-2021 28-Dec-2022 12,684.00
Qu, Dr. Jun Modeling Mechanisms of Adjuvanted Influenza Vaccine Induced IgG Repertoire Diversity and Heterosubtypic Immunity URF (AWD00001405) Federal Flow Through University of Rochester 1-Feb-17 31-Jan-22 472,621.00
Qu, Dr. Jun GMPS-GMPR axis melanoma progression and therapy Federal Flow Through Wake Forest University Health Sciences 23-Nov-18 30-Apr-23 102,352.00
Qu, Dr. Jun Comprehensive characterization of upregulated proteases in diseased vs normal tissues Nonfederal AbbVie Incorporated 19-Jun-19 31-Dec-21 224,675.00
Qu, Dr. Jun Novel LC-MS strategies for comprehensive investigations of Circulating Immune Complext and MHC Presenting Peptides Nonfederal GlaxoSmithKline 8-Jul-19 31-Aug-21 434,493.00
Qu, Dr. Jun Neuroinflammation-related phosphoprotein signaling pathways as potential therapeutic targets for GWI using an established animal model Federal Flow Through West Virginia Univ. Research Corp. on behalf of West Virginia Univ. 1-Feb-20 31-Jan-22 103,669.00
Qu, Dr. Jun The Network Biology of Pathogen-Host Interactions Driving Exacerbation in Chronic Obstructive Pulmonary Disease (COPD) Federal Flow Through Buffalo Institute for Medical Research 15-Sep-19 14-Sep-22 335,351.00
Qu, Dr. Jun Highly sensitive multiplexed targeted mass spectrometric assays of proteins/peptides of significance in obesity research Federal Flow Through Pacific Northwest National Laboratory 19-Feb-20 31-Jul-23 618,520.00
Qu, Dr. Jun Extracellular Vesicle treatment and age-related neuropathology in non-human primates Federal Flow Through Trustees of Boston University 15-Sep-20 30-Apr-25 191,400.00
Qu, Dr. Jun Alternative Polyadenylation as a Novel Mediator of Therapeutic Resistance in Lung Cancer Federal Flow Through Health Research Inc 01-Jul-2021 30-Jun-2022 14,645.00
Qu, Dr. Jun Role of Type 2 Immune Response in Pancreatic Cancer Tumorgenisis Federal Flow Through Health Research Inc 15-Jul-2021 30-Jun-2022 9,943.00
Ramanathan, Dr. Murali The Metabolomics-Neurofilaments-Neurodegeneration Nexus in Multiple Sclerosis Progression Federal US Army Medical Research Acquisition Activity 1-Jul-20 30-Jun-23 957,000.00
Shah, Dr. Dhavalkumar Development of a quantitative systems pharmacology (QSP) Model to Support Clinical Translation of adeno-associated virus (AAV) Vectorized Brain Delivery of Anti-a-Synuclein (AS) Antibody Foreign AstraZeneca UK Limited 13-Jul-20 12-Jul-22 252,800.00
Shah, Dr. Dhavalkumar C19: UB CAT: Big-Data and AI Driven De Novo Discovery of Novel Antibodies For COVID-19 Nonfederal Manhattan BioSolutions LLC 1-Jul-21 30-Jun-22 3,500.00
Sprowl, Dr. Jason Arthur Regulation of hepatic uptake transporters by tyrosine kinases Federal National Institute of General Medical Sciences 15-Sep-2021 31-Aug-2026 2,321,588.00
Straubinger, Dr. Robert M Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer Federal National Cancer Institute 1-Jul-15 31-Aug-21 2,156,820.00
Straubinger, Dr. Robert M Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development Federal National Cancer Institute 21-Dec-18 30-Nov-21 398,683.00
Tornatore, Dr. Kathleen M Age and Race Influences on Immunosuppression after Renal Transplant Federal National Institute on Aging 15-Aug-18 30-Jun-23 3,507,814.00
Tsuji, Dr. Brian T Novel Strategies for Antibiotic Combinations to Combat Gram-negative Superbugs Federal National Institute of Allergy & Infectious Disease 20-Dec-19 30-Nov-24 3,920,362.00
Tsuji, Dr. Brian T Exploitation of multiple heteroresistance for effective antibiotic combination therapy Federal Flow Through Emory University 1-Jul-20 30-Sep-21 126,770.20
Woo, Dr. Sukyung Overcoming Resistance to Anti-VEGF Therapy with Predictive Modeling Nonfederal American Cancer Society 9-Dec-19 31-Dec-21 298,793.66
Woo, Dr. Sukyung Role of p66Shc in Regulation of Microvascular Reactivity of Renal Blood Vessels Federal Flow Through Board of Regents of the University of Oklahoma 01-Jul-2020 30-Jun-2022 15,918.00
Woo, Dr. Sukyung Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition Federal National Cancer Institute 01-Dec-2021 30-Nov-2026 2,018,141.00
Xu, Dr. Ying Preclinical Evaluation of Tetra Compounds in Mice Nonfederal Tetra Discovery Partners 18-Jan-21 31-Jan-22 188,791.00
Xu, Dr. Ying Role of PDE2A in mitochondrial dysfunction in Alzheimer's disease Federal National Institute on Aging 15-Aug-2021 30-Apr-2026 3,899,264.00
Xu, Dr. Ying SBIR: Discovery of PDE2A inhibitors to treat memory deficits in mild cognitive impairment and Alzheimer's disease Federal Flow Through FD NeuroTechnologies Incorporated 01-Sep-2021 31-Aug-2022 91,665.00
You, Dr. Young Jae Mechanistic studies of gamma-glutamyl transpeptidase inhibition: A novel approach to modulating serum levels of cysteine Federal Flow Through Board of Regents of the University of Oklahoma 1-Jan-20 31-Aug-22 121,218.00